Navigation Links
NAMSA opens Shanghai office

NORTHWOOD, Ohio, Sept. 20, 2012 /PRNewswire/ -- NAMSA, the world's leading medical device research organization, has opened its newest office in Shanghai, China.

(Photo: )

The new office will provide improved convenience and efficiency for NAMSA's clients in China and around the world. The Shanghai office allows NAMSA to better support Chinese manufacturers in meeting European and U.S. regulatory requirements. Additionally, the company is better positioned to assist device manufacturers outside China to meet the necessary standards for marketing products in China.

"This expansion benefits all of NAMSA's current and potential clients," said An Liu, general manager, NAMSA China. "Chinese manufacturers can trust in our proven ability to successfully support meeting European and U.S. regulatory requirements, while those manufacturers outside China aiming to distribute products within China can rely on our expertise and proximity for convenient assistance in meeting the country's regulatory demands."

In his new role, Liu is responsible for establishing and developing NAMSA China business. He previously served as director of biostatistics and data management for NAMSA. Before joining NAMSA, Liu served as statistics manager for Medtronic.

"NAMSA is pleased to be in a position to expand and better serve our partners with world-class expertise in regulatory, non-clinical and clinical research services," said Terence Langenderfer, Director of Global Marketing, NAMSA. "It has always been our intention to provide the best strategic guidance and tactical support in the most cost-effective and seamless manner. This expansion in China supports that mission."

To coincide with the opening of the Shanghai office, NAMSA will be presenting at MEDTEC China – the international regulatory conference for the medical device manufacturing industry – on Sept. 26. In addition to Liu, who will present on "Cardiovascular Devices: US FDA Regulatory Requirement and Clinical Trial Design", Dr. Jean Pierre Boutrand, general manager of NAMSA in Lyon, France, and one of NAMSA's top biocompatibility experts, will present on European regulations.

These presenters will be available to meet with participants at MEDTEC China exhibit hall; booth 1501.

NAMSA ( is a global medical device research organization providing a comprehensive range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. For more than 45 years, NAMSA clients have utilized its testing and consulting services to bring safe and effective therapies to market.

Contact Information
For further information about NAMSA, contact:
Sean Hamilton
Marketing Communications Manager

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vesta Inc. Opens Frankfurt Office to Increase Service to Their Growing Medical Device Contracting Business Overseas
2. German-based Contract Research Organization Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech
3. Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at Midwest Immunology Clinic
4. Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida
5. Arizonas Newest Medical School Opens
6. Scotland-based Innova Partnerships Ltd. Opens Boston Office
7. RxAlly Opens Its Doors In Leesburg, Virginia
8. Clinilabs Opens Phase I Unit In Eatontown, New Jersey
9. Marken Opens Branch Office In Seoul, South Korea
10. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
11. Synchrogenix Opens in Sweden
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):